Mahony Susan — SEC Form 4 filings
SEC reporting owner CIK 1463321. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-10.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-29 to 2026-06-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 600 shares, $145,017 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 300 shares @ $246.18 ($73,854) in Axsome Therapeutics, Inc., filed 2026-06-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | Director | 6 | — | 2 legs · 600 sh · $145,017 | 8 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | Director | 3 | — | — | 3 |
| Zymeworks Inc. (ZYME) | Director | 2 | — | — | 3 |
Form 4 filings — Mahony Susan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-10 | 4 | Axsome Therapeutics, Inc. (AXSM) | Option exercise (M): 1,429 · Sale (S): 300 @ $237.21 · Sale (S): 300 @ $246.18 · Option exercise (M): 1,429 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 1,721 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | ASSEMBLY BIOSCIENCES, INC. (ASMB) | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 11,500 (derivative) @ $0 · Grant/award (A): 7,700 (derivative) @ $0 | EDGAR |
| 2025-06-10 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 3,166 (derivative) @ $0 · Grant/award (A): 1,429 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | ASSEMBLY BIOSCIENCES, INC. (ASMB) | Grant/award (A): 3,500 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 1,312 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | Zymeworks Inc. (ZYME) | Grant/award (A): 31,000 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 5,799 (derivative) @ $0 | EDGAR |
| 2024-05-30 | 4 | ASSEMBLY BIOSCIENCES, INC. (ASMB) | Grant/award (A): 2,750 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 191 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1463321 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →